March 24, 2015
The lead plaintiff in an investor class action against now-bankrupt experimental drug company PolyMedix Inc. asked a Pennsylvania federal judge on Monday to approve a $1.15 million settlement with nearly $400,000 in attorneys' fees.
July 02, 2012
PolyMedix Inc. was slapped with a lawsuit in Pennsylvania federal court Monday by a putative class of investors who say the experimental drug company misled the public about a flawed anti-stroke treatment in order to generate buzz for a $20 million stock offering.